Screener
Zevra Therapeutics, Inc. ZVRA Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Operating lease right-of-use assets | 1,667 | 1,212 |
| Goodwill | 4,701 | 4,701 |
| Intangible assets, net | 5,789 | 6,421 |
| Other long-term assets | 3 | 143 |
| Total assets | $302,712 | $284,731 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable and accrued expenses | $13,962 | $11,598 |
ITEM 1.FINANCIAL STATEMENTS
FAQ
- What is Zevra Therapeutics, Inc.'s other non-current assets?
- Zevra Therapeutics, Inc. (ZVRA) reported other non-current assets of $3K in Q2 2026.
- How has Zevra Therapeutics, Inc.'s other non-current assets changed year-over-year?
- Zevra Therapeutics, Inc.'s other non-current assets decreased by 98.6% year-over-year, from $220K to $3K.
- What is the long-term trend for Zevra Therapeutics, Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s other non-current assets has grown at a -20.1% compound annual growth rate (CAGR), from $438K to $143K.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Zevra Therapeutics, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude